{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:25:26Z","timestamp":1787930726561,"version":"build-2784847793"},"reference-count":135,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["vetsmall.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Small Animal Practice"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.cvsm.2015.06.004","type":"journal-article","created":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T04:48:10Z","timestamp":1440823690000},"page":"1235-1259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Medical Treatment of Primary Canine Glaucoma"],"prefix":"10.1016","volume":"45","author":[{"given":"Anthony F.","family":"Alario","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis D.","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pizzirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.cvsm.2015.06.004_bib1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/archopht.126.7.959","article-title":"Intraocular pressure response to topical beta-blockers associated with an ADRB2 single-nucleotide polymorphism","volume":"126","author":"McCarty","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.cvsm.2015.06.004_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bjophthalmol-2013-304267","article-title":"Association between genetic polymorphisms of the prostaglandin F2alpha receptor gene, and response to latanoprost in patients with glaucoma and ocular hypertension","volume":"98","author":"Sakurai","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.cvsm.2015.06.004_bib3","series-title":"Veterinary Ophthalmology","first-page":"1050","article-title":"The canine glaucomas","author":"Plummer","year":"2013"},{"key":"10.1016\/j.cvsm.2015.06.004_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.cvsm.2015.06.005","article-title":"Functional anatomy of the outflow facilities","author":"Pizzirani","year":"2015","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"2","key":"10.1016\/j.cvsm.2015.06.004_bib5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2460\/ajvr.1993.54.02.287","article-title":"Effect of topically applied demecarium bromide and echothiophate iodide on intraocular pressure and pupil size in beagles with normotensive eyes and beagles with inherited glaucoma","volume":"54","author":"Gum","year":"1993","journal-title":"Am J Vet Res"},{"issue":"10","key":"10.1016\/j.cvsm.2015.06.004_bib6","first-page":"1198","article-title":"Reduction of intraocular pressure in glaucomatous dogs by a new cholinergic drug","volume":"19","author":"Chiou","year":"1980","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.cvsm.2015.06.004_bib7","first-page":"1143","article-title":"The effect of topical pilocarpine on intraocular pressure and pupil size in the normotensive and glaucomatous beagle","volume":"16","author":"Gwin","year":"1977","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 1","key":"10.1016\/j.cvsm.2015.06.004_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1463-5224.2011.00958.x","article-title":"Effects of an unfixed combination of latanoprost and pilocarpine on the intraocular pressure and pupil size of normal dogs","volume":"15","author":"Sarchahi","year":"2012","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.cvsm.2015.06.004_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.exer.2012.11.003","article-title":"Pilocarpine-induced flare is physiological rather than pathological","volume":"107","author":"Freddo","year":"2013","journal-title":"Exp Eye Res"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib10","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.exer.2005.07.019","article-title":"Pilocarpine's effects on the blood-aqueous barrier of the human eye as assessed by high-resolution, contrast magnetic resonance imaging","volume":"82","author":"Freddo","year":"2006","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1463-5224.2009.00748.x","article-title":"Effect of three treatment protocols on acute ocular hypertension after phacoemulsification and aspiration of cataracts in dogs","volume":"13","author":"Crasta","year":"2010","journal-title":"Vet Ophthalmol"},{"issue":"12","key":"10.1016\/j.cvsm.2015.06.004_bib12","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2460\/javma.1998.212.12.1885","article-title":"Effect of intracameral administration of carbachol on the postoperative increase in intraocular pressure in dogs undergoing cataract extraction","volume":"212","author":"Stuhr","year":"1998","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"5","key":"10.1016\/j.cvsm.2015.06.004_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.5326\/15473317-36-5-431","article-title":"The efficacy of topical prophylactic antiglaucoma therapy in primary closed angle glaucoma in dogs: a multicenter clinical trial","volume":"36","author":"Miller","year":"2000","journal-title":"J\u00a0Am Anim Hosp Assoc"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/vop.12069","article-title":"Efficacy of prophylactic antiglaucoma and anti-inflammatory medications in canine primary angle-closure glaucoma: a multicenter retrospective study (2004-2012)","volume":"17","author":"Dees","year":"2014","journal-title":"Vet Ophthalmol"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2460\/javma.231.1.89","article-title":"Outcomes of nonsurgical management and efficacy of demecarium bromide treatment for primary lens instability in dogs: 34 cases (1990\u20132004)","volume":"231","author":"Binder","year":"2007","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/108076802317233216","article-title":"Effects of multiple dosing of epinephrine on aqueous humor dynamics in human eyes","volume":"18","author":"Wang","year":"2002","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib17","first-page":"256","article-title":"Immediate effect of epinephrine on aqueous formation in the normal human eye as measured by fluorophotometry","volume":"19","author":"Townsend","year":"1980","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.cvsm.2015.06.004_bib18","first-page":"2507","article-title":"Effect of chronic epinephrine on aqueous humor flow during the day and during sleep in normal healthy subjects","volume":"32","author":"Schneider","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.cvsm.2015.06.004_bib19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/exer.1998.0623","article-title":"Effects of topical epinephrine on aqueous humor dynamics in the cat","volume":"68","author":"Wang","year":"1999","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2460\/ajvr.1978.39.01.83","article-title":"Effects of topical 1-epinephrine and dipivalyl epinephrine on intraocular pressure and pupil size in the normotensive and glaucomatous Beagle","volume":"39","author":"Gwin","year":"1978","journal-title":"Am J Vet Res"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.exer.2011.04.002","article-title":"Update on the role of alpha-agonists in glaucoma management","volume":"93","author":"Arthur","year":"2011","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2460\/ajvr.1996.57.01.79","article-title":"Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal dogs","volume":"57","author":"Miller","year":"1996","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2460\/ajvr.1996.57.01.83","article-title":"Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal cats","volume":"57","author":"Miller","year":"1996","journal-title":"Am J Vet Res"},{"issue":"4","key":"10.1016\/j.cvsm.2015.06.004_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1463-5224.2002.00222.x","article-title":"Effect of single and multiple doses of 0.2% brimonidine tartrate in the glaucomatous Beagle","volume":"5","author":"Gelatt","year":"2002","journal-title":"Vet Ophthalmol"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1463-5224.2004.04010.x","article-title":"Effects of topical nipradilol and timolol maleate on intraocular pressure, facility of outflow, arterial blood pressure and pulse rate in dogs","volume":"7","author":"Maehara","year":"2004","journal-title":"Vet Ophthalmol"},{"issue":"8","key":"10.1016\/j.cvsm.2015.06.004_bib26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/j.1552-4604.1994.tb02042.x","article-title":"Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension","volume":"34","author":"Frishman","year":"1994","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.cvsm.2015.06.004_bib27","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2460\/ajvr.1995.56.10.1325","article-title":"Evaluation of multiple doses of 4 and 6% timolol, and timolol combined with 2% pilocarpine in clinically normal beagles and beagles with glaucoma","volume":"56","author":"Gelatt","year":"1995","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2015.06.004_bib28","first-page":"141","article-title":"The effect of topical timolol maleate on intraocular pressure in normal beagles and beagles with inherited glaucoma","volume":"1","author":"Gum","year":"1991","journal-title":"Progress in Veterinary and Comparative Ophthalmology"},{"issue":"4","key":"10.1016\/j.cvsm.2015.06.004_bib29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1463-5224.2006.00469.x","article-title":"Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs","volume":"9","author":"Plummer","year":"2006","journal-title":"Vet Ophthalmol"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/02713683.2011.630154","article-title":"Drug delivery by contact lens in spontaneously glaucomatous dogs","volume":"37","author":"Peng","year":"2012","journal-title":"Curr Eye Res"},{"issue":"9","key":"10.1016\/j.cvsm.2015.06.004_bib31","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2460\/ajvr.71.9.1055","article-title":"Effects of topical administration of latanoprost, timolol, or a combination of latanoprost and timolol on intraocular pressure, pupil size, and heart rate in clinically normal dogs","volume":"71","author":"Smith","year":"2010","journal-title":"Am J Vet Res"},{"issue":"6","key":"10.1016\/j.cvsm.2015.06.004_bib32","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1292\/jvms.68.631","article-title":"The effects of a timolol maleate gel-forming solution on normotensive beagle dogs","volume":"68","author":"Takiyama","year":"2006","journal-title":"J\u00a0Vet Med Sci"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib33","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2460\/ajvr.1991.52.03.432","article-title":"Effects of topical administration of timolol maleate on intraocular pressure and pupil size in dogs","volume":"52","author":"Wilkie","year":"1991","journal-title":"Am J Vet Res"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib34","first-page":"401","article-title":"Therapeutic and systemic side effects of ocular beta-adrenergic antagonists in anesthetized dogs","volume":"27","author":"Svec","year":"1986","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.cvsm.2015.06.004_bib35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0039-6257(79)90228-5","article-title":"The beta-adrenergic blocking agents and the treatment of glaucoma","volume":"23","author":"Zimmerman","year":"1979","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib36","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2460\/ajvr.1991.52.03.436","article-title":"Effects of topical administration of timolol maleate on intraocular pressure and pupil size in cats","volume":"52","author":"Wilkie","year":"1991","journal-title":"Am J Vet Res"},{"issue":"5","key":"10.1016\/j.cvsm.2015.06.004_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1742-7843.2011.00694.x","article-title":"Metabolism of ophthalmic timolol: new aspects of an old drug","volume":"108","author":"Volotinen","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1463-5216.2001.00202.x","article-title":"Advances in topical glaucoma therapy","volume":"5","author":"Willis","year":"2002","journal-title":"Vet Ophthalmol"},{"issue":"4","key":"10.1016\/j.cvsm.2015.06.004_bib39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/jop.1993.9.373","article-title":"Topical ophthalmic beta blockers: a comparative review","volume":"9","author":"Zimmerman","year":"1993","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.cvsm.2015.06.004_bib40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11259-009-9273-9","article-title":"Comparison of effects of topical levobunolol to a combination of timolol-dorzolamide on intraocular pressure and pulse rate of healthy dogs","volume":"33","author":"Pugliese","year":"2009","journal-title":"Vet Res Commun"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib41","first-page":"E1","article-title":"Effects of topical 0.5% levobunolol alone or in association with 2% dorzolamide compared with a fixed combination of 0.5% timolol and 2% dorzolamide on intraocular pressure and heart rate in dogs without glaucoma","volume":"11","author":"Scardillo","year":"2010","journal-title":"Vet Ther"},{"issue":"2","key":"10.1016\/j.cvsm.2015.06.004_bib42","first-page":"539","article-title":"Expression of carbonic anhydrase isozyme III in the ciliary processes and lens","volume":"38","author":"Jampel","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1350-9462(99)00006-3","article-title":"Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors","volume":"19","author":"Sugrue","year":"2000","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1463-5224.2001.00141.x","article-title":"Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs","volume":"4","author":"Gelatt","year":"2001","journal-title":"Vet Ophthalmol"},{"issue":"2","key":"10.1016\/j.cvsm.2015.06.004_bib45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2460\/ajvr.2003.64.183","article-title":"Effects of oral administration of methazolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs","volume":"64","author":"Skorobohach","year":"2003","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/jop.1997.13.23","article-title":"Ocular absorption, blood levels, and excretion of dorzolamide, a topically active carbonic anhydrase inhibitor","volume":"13","author":"Maren","year":"1997","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cvsm.2015.06.004_bib47","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2460\/ajvr.2001.62.859","article-title":"Effects of topical application of a 2% solution of dorzolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs","volume":"62","author":"Cawrse","year":"2001","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2015.06.004_bib48","unstructured":"Whelan NC, Welch P, Pace A, et\u00a0al. A comparison of the efficacy of topical brinzolamide and dorzolamide alone and in combination with oral methazolamide in decreasing normal canine intraocular pressure. 30th Annual Meeting of the Americal College of Veterinary Ophthalmologists. Chicago (IL), October 1999."},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib49","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cvsm.2004.02.001","article-title":"Ocular hypotensive drugs","volume":"34","author":"Willis","year":"2004","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/2040622313511286","article-title":"Glaucoma management: relative value and place in therapy of available drug treatments","volume":"5","author":"Sambhara","year":"2014","journal-title":"Ther Adv Chronic Dis"},{"issue":"10","key":"10.1016\/j.cvsm.2015.06.004_bib51","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1167\/iovs.02-1281","article-title":"Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide","volume":"44","author":"Richter","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl1","key":"10.1016\/j.cvsm.2015.06.004_bib52","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.survophthal.2008.08.010","article-title":"Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction","volume":"53","author":"Toris","year":"2008","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"10.1016\/j.cvsm.2015.06.004_bib53","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archopht.119.8.1165","article-title":"Increased matrix metalloproteinases 1, 2, and 3 in the monkey uveoscleral outflow pathway after topical prostaglandin F(2 alpha)-isopropyl ester treatment","volume":"119","author":"Gaton","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.cvsm.2015.06.004_bib54","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1167\/iovs.08-3356","article-title":"Effect of bimatoprost, latanoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human ciliary body smooth muscle cells","volume":"50","author":"Ooi","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.cvsm.2015.06.004_bib55","first-page":"2554","article-title":"Enhanced FGF-2 movement through human sclera after exposure to latanoprost","volume":"42","author":"Aihara","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.cvsm.2015.06.004_bib56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1463-5224.2010.00832.x","article-title":"Effect of topical 0.03% flurbiprofen and 0.005% latanoprost, alone and in combination, on normal canine eyes","volume":"14","author":"Pirie","year":"2011","journal-title":"Vet Ophthalmol"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib57","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/bjo.2005.080895","article-title":"Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension","volume":"90","author":"Chiba","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.cvsm.2015.06.004_bib58","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2460\/ajvr.2000.61.1220","article-title":"Effects of 0.005% latanoprost solution on intraocular pressure in healthy dogs and cats","volume":"61","author":"Studer","year":"2000","journal-title":"Am J Vet Res"},{"issue":"4","key":"10.1016\/j.cvsm.2015.06.004_bib59","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1463-5216.2001.00201.x","article-title":"Effect of different dose schedules of latanoprost on intraocular pressure and pupil size in the glaucomatous Beagle","volume":"4","author":"Gelatt","year":"2001","journal-title":"Vet Ophthalmol"},{"issue":"2","key":"10.1016\/j.cvsm.2015.06.004_bib60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1463-5224.2006.00441.x","article-title":"Effects of travoprost 0.004% compared with latanoprost 0.005% on the intraocular pressure of normal dogs","volume":"9","author":"Carvalho","year":"2006","journal-title":"Vet Ophthalmol"},{"issue":"6","key":"10.1016\/j.cvsm.2015.06.004_bib61","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/108076802321021072","article-title":"Effect of different dose schedules of bimatoprost on intraocular pressure and pupil size in the glaucomatous Beagle","volume":"18","author":"Gelatt","year":"2002","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib62","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1463-5224.2004.00326.x","article-title":"Effect of different dose schedules of travoprost on intraocular pressure and pupil size in the glaucomatous Beagle","volume":"7","author":"Gelatt","year":"2004","journal-title":"Vet Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.cvsm.2015.06.004_bib63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1463-5224.2011.00934.x","article-title":"Dose response for travoprost(R) in the glaucomatous beagle","volume":"15","author":"Mackay","year":"2012","journal-title":"Vet Ophthalmol"},{"issue":"4","key":"10.1016\/j.cvsm.2015.06.004_bib64","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/vop.12142","article-title":"Trans-corneal reduction of anterior lens luxation in dogs with lens instability: a retrospective study of 19 dogs (2010-2013)","volume":"17","author":"Montgomery","year":"2014","journal-title":"Vet Ophthalmol"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib65","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1463-5224.2008.00609.x","article-title":"The effect of a single dose of topical 0.005% latanoprost and 2% dorzolamide\/0.5% timolol combination on the blood-aqueous barrier in dogs: a pilot study","volume":"11","author":"Johnstone McLean","year":"2008","journal-title":"Vet Ophthalmol"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib66","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/112067210801800315","article-title":"A\u00a05-year, randomized, open-label safety study of latanoprost and usual care in patients with open-angle glaucoma or ocular hypertension","volume":"18","author":"Goldberg","year":"2008","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"10.1016\/j.cvsm.2015.06.004_bib67","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00417-009-1036-3","article-title":"Efficacy and safety of latanoprost in eyes with uveitic glaucoma","volume":"247","author":"Markomichelakis","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.cvsm.2015.06.004_bib68","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1463-5224.2006.00467.x","article-title":"Comparison of the effect of hypertonic hydroxyethyl starch and mannitol on the intraocular pressure in healthy normotensive dogs and the effect of hypertonic hydroxyethyl starch on the intraocular pressure in dogs with primary glaucoma","volume":"9","author":"Volopich","year":"2006","journal-title":"Vet Ophthalmol"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib69","first-page":"249","article-title":"The effect of intravenous mannitol or oral glycerol on intraocular pressure in dogs","volume":"79","author":"Lorimer","year":"1989","journal-title":"Cornell Vet"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1463-5224.2012.01011.x","article-title":"Effects of oral isosorbide and glycerol on intraocular pressure, serum osmolality, and blood glucose in normal dogs","volume":"16","author":"Wasserman","year":"2013","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.cvsm.2015.06.004_bib71","unstructured":"Pizzirani S, Carroll V, Pirie CG, et\u00a0al. Pathological factors involved with the late onset of canine glaucoma associated with goniodysgenesis: preliminary study. Presented at the 39th Annual Meeting of the American College of Veterinary Ophthalmologists. Boston (MA), October 2008."},{"issue":"4","key":"10.1016\/j.cvsm.2015.06.004_bib72","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1463-5224.2005.00399.x","article-title":"Canine goniodysgenesis-related glaucoma: a morphologic review of 100 cases looking at inflammation and pigment dispersion","volume":"8","author":"Reilly","year":"2005","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.cvsm.2015.06.004_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.cvsm.2015.06.002","article-title":"Definition, classification, and pathophysiology of canine glaucoma","author":"Pizzirani","year":"2015","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"Suppl","key":"10.1016\/j.cvsm.2015.06.004_bib74","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.4103\/0301-4738.73700","article-title":"Neuroprotection in glaucoma","volume":"59","author":"Vasudevan","year":"2011","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"10.1016\/j.cvsm.2015.06.004_bib75","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/14728222.2014.888416","article-title":"Newer targets for modulation of intraocular pressure: focus on adenosine receptor signaling pathways","volume":"18","author":"Agarwal","year":"2014","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib76","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1517\/14728214.2011.521631","article-title":"Emerging drugs for ocular hypertension","volume":"16","author":"Lee","year":"2011","journal-title":"Expert Opin Emerg Drugs"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/02713683.2011.622849","article-title":"Endothelin and its suspected role in the pathogenesis and possible treatment of glaucoma","volume":"37","author":"Shoshani","year":"2012","journal-title":"Curr Eye Res"},{"issue":"6122","key":"10.1016\/j.cvsm.2015.06.004_bib78","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/327524a0","article-title":"Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor","volume":"327","author":"Palmer","year":"1987","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cvsm.2015.06.004_bib79","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.57.4.3","article-title":"Carbon monoxide: endogenous production, physiological functions, and pharmacological applications","volume":"57","author":"Wu","year":"2005","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.cvsm.2015.06.004_bib80","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/j.gastro.2014.04.041","article-title":"Carbon monoxide, hydrogen sulfide, and nitric oxide as signaling molecules in the gastrointestinal tract","volume":"147","author":"Farrugia","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cvsm.2015.06.004_bib81","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2011.01.013","article-title":"Carbon monoxide and the eye: Implications for glaucoma therapy","volume":"130","author":"Bucolo","year":"2011","journal-title":"Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.cvsm.2015.06.004_bib82","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1167\/iovs.14-14515","article-title":"Nitric oxide (NO): an emerging target for the treatment of glaucoma","volume":"55","author":"Cavet","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.cvsm.2015.06.004_bib83","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3109\/02713683.2012.700753","article-title":"Heme oxygenase and ocular disease: a review of the literature","volume":"37","author":"Zhao","year":"2012","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib84","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1073\/pnas.98.1.355","article-title":"The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2","volume":"98","author":"Thomas","year":"2001","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.cvsm.2015.06.004_bib85","first-page":"43","article-title":"Nitric oxide signaling: would you believe that a simple free radical could be a second messenger, autacoid, paracrine substance, neurotransmitter, and hormone?","volume":"53","author":"Murad","year":"1998","journal-title":"Recent Prog Horm Res"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib86","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0039-6257(97)84043-X","article-title":"Nitric oxide in the eye: multifaceted roles and diverse outcomes","volume":"42","author":"Becquet","year":"1997","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.cvsm.2015.06.004_bib87","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/jop.2009.0120","article-title":"A\u00a0novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma","volume":"26","author":"Borghi","year":"2010","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib88","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.exer.2011.02.006","article-title":"A\u00a0dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs","volume":"93","author":"Impagnatiello","year":"2011","journal-title":"Exp Eye Res"},{"issue":"6","key":"10.1016\/j.cvsm.2015.06.004_bib89","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1159\/000335866","article-title":"Guanylate cyclase activators, cell volume changes and IOP reduction","volume":"28","author":"Ellis","year":"2011","journal-title":"Cell Physiol Biochem"},{"issue":"8","key":"10.1016\/j.cvsm.2015.06.004_bib90","first-page":"1711","article-title":"Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye","volume":"37","author":"Behar-Cohen","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib91","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/exer.1994.1199","article-title":"Nitrovasodilator effects on intraocular pressure and outflow facility in monkeys","volume":"58","author":"Schuman","year":"1994","journal-title":"Exp Eye Res"},{"issue":"13","key":"10.1016\/j.cvsm.2015.06.004_bib92","doi-asserted-by":"crossref","first-page":"9438","DOI":"10.1167\/iovs.11-7839","article-title":"eNOS, a pressure-dependent regulator of intraocular pressure","volume":"52","author":"Stamer","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib93","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0022-3565(25)11469-9","article-title":"Nitrovasodilators as a new class of ocular hypotensive agents","volume":"260","author":"Nathanson","year":"1992","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib94","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/108076802317233171","article-title":"Comparison of nitric oxide donors in lowering intraocular pressure in rabbits: role of cyclic GMP","volume":"18","author":"Kotikoski","year":"2002","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.cvsm.2015.06.004_bib95","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/978-1-4614-3209-8_94","article-title":"Nipradilol promotes axon regeneration through S-nitrosylation of PTEN in retinal ganglion cells","volume":"801","author":"Koriyama","year":"2014","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"10.1016\/j.cvsm.2015.06.004_bib96","first-page":"1642","article-title":"The effect of NO donors on bovine retinal small arteries and posterior ciliary arteries","volume":"39","author":"Delaey","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.cvsm.2015.06.004_bib97","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000139443","article-title":"Canine retinal arterial and arteriolar dilatation induced by nipradilol, a possible glaucoma therapeutic","volume":"53","author":"Okamura","year":"1996","journal-title":"Pharmacology"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib98","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/108076801750295263","article-title":"Intraocular pressure and vascular effects of sodium azide in bovine perfused eye","volume":"17","author":"Millar","year":"2001","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib99","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.bjp.0706156","article-title":"Cyclic GMP, sodium nitroprusside and sodium azide reduce aqueous humour formation in the isolated arterially perfused pig eye","volume":"145","author":"Shahidullah","year":"2005","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/02713689609017615","article-title":"Short-term hemodynamic changes in episcleral arteriovenous anastomoses correlate with venous pressure and IOP changes in the albino rabbit","volume":"15","author":"Funk","year":"1996","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib101","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/IJG.0b013e3181752c6f","article-title":"Neuroprotective effect of nipradilol [3,4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran] in a rat model of optic nerve degeneration","volume":"18","author":"Karim","year":"2009","journal-title":"J\u00a0Glaucoma"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib102","first-page":"688","article-title":"Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action","volume":"42","author":"Mizuno","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.cvsm.2015.06.004_bib103","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.neuroscience.2006.02.016","article-title":"Axonal regeneration of cat retinal ganglion cells is promoted by nipradilol, an anti-glaucoma drug","volume":"140","author":"Watanabe","year":"2006","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.cvsm.2015.06.004_bib104","first-page":"1765","article-title":"Identification of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye","volume":"36","author":"Nathanson","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.cvsm.2015.06.004_bib105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/niox.1998.0189","article-title":"Neuronal-type NO synthase: transcript diversity and expressional regulation","volume":"2","author":"Boissel","year":"1998","journal-title":"Nitric Oxide"},{"issue":"8","key":"10.1016\/j.cvsm.2015.06.004_bib106","first-page":"2184","article-title":"Efferent and afferent innervation of primate trabecular meshwork and scleral spur","volume":"41","author":"Selbach","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.cvsm.2015.06.004_bib107","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrm1128","article-title":"Rocks: multifunctional kinases in cell behaviour","volume":"4","author":"Riento","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.cvsm.2015.06.004_bib108","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/10409238.2013.786671","article-title":"Rho-associated coiled-coil kinase (ROCK) signaling and disease","volume":"48","author":"Schofield","year":"2013","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"5","key":"10.1016\/j.cvsm.2015.06.004_bib109","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1161\/CIRCRESAHA.116.305720","article-title":"Between Rho(k) and a hard place: the relation between vessel wall stiffness, endothelial contractility, and cardiovascular disease","volume":"116","author":"Huveneers","year":"2015","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.cvsm.2015.06.004_bib110","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/embor.2012.127","article-title":"Rho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapy","volume":"13","author":"Rath","year":"2012","journal-title":"EMBO Rep"},{"key":"10.1016\/j.cvsm.2015.06.004_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2013.05.002","article-title":"Rho-associated kinase inhibitors: a novel glaucoma therapy","volume":"37","author":"Inoue","year":"2013","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"10.1016\/j.cvsm.2015.06.004_bib112","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3109\/02713683.2013.874444","article-title":"Effects of K-115, a rho-kinase inhibitor, on aqueous humor dynamics in rabbits","volume":"39","author":"Isobe","year":"2014","journal-title":"Curr Eye Res"},{"issue":"Suppl 11","key":"10.1016\/j.cvsm.2015.06.004_bib113","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/ICO.0000000000000240","article-title":"New therapeutic modality for corneal endothelial disease using Rho-associated kinase inhibitor eye drops","volume":"33","author":"Koizumi","year":"2014","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.cvsm.2015.06.004_bib114","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1167\/iovs.13-13157","article-title":"AMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia","volume":"55","author":"Van de Velde","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1242\/dev.111583","article-title":"Rho kinase activity controls directional cell movements during primitive streak formation in the rabbit embryo","volume":"142","author":"Stankova","year":"2015","journal-title":"Development"},{"issue":"5","key":"10.1016\/j.cvsm.2015.06.004_bib116","first-page":"1029","article-title":"Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632","volume":"42","author":"Rao","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cvsm.2015.06.004_bib117","first-page":"2561","article-title":"Contractile markers distinguish structures of the mouse aqueous drainage tract","volume":"19","author":"Ko","year":"2013","journal-title":"Mol Vis"},{"issue":"2\u20133","key":"10.1016\/j.cvsm.2015.06.004_bib118","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/jop.2013.0192","article-title":"Morphological and hydrodynamic correlations with increasing outflow facility by rho-kinase inhibitor Y-27632","volume":"30","author":"Gong","year":"2014","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"issue":"18","key":"10.1016\/j.cvsm.2015.06.004_bib119","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s40265-014-0333-2","article-title":"Ripasudil: first global approval","volume":"74","author":"Garnock-Jones","year":"2014","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.cvsm.2015.06.004_bib120","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1167\/iovs.12-10930","article-title":"Effects of Y27632 on aqueous humor outflow facility with changes in hydrodynamic pattern and morphology in human eyes","volume":"54","author":"Yang","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib121","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1167\/iovs.10-5265","article-title":"Effects of fasudil, a Rho-associated protein kinase inhibitor, on optic nerve head blood flow in rabbits","volume":"52","author":"Sugiyama","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.cvsm.2015.06.004_bib122","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1167\/iovs.07-0878","article-title":"Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery","volume":"48","author":"Honjo","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib123","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1517\/17425240902798119","article-title":"Intraocular penetration of antimicrobial agents in ophthalmic infections and drug delivery strategies","volume":"6","author":"Velpandian","year":"2009","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib124","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4155\/tde.10.40","article-title":"Recent advances in ophthalmic drug delivery","volume":"1","author":"Kompella","year":"2010","journal-title":"Ther Deliv"},{"issue":"3","key":"10.1016\/j.cvsm.2015.06.004_bib125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1586\/erd.09.4","article-title":"Drug delivery systems for the eye","volume":"6","author":"Kearns","year":"2009","journal-title":"Expert Rev Med Devices"},{"issue":"Pt 2","key":"10.1016\/j.cvsm.2015.06.004_bib126","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/eye.1998.56","article-title":"Compliance with timolol treatment in glaucoma","volume":"12","author":"Rotchford","year":"1998","journal-title":"Eye"},{"issue":"6","key":"10.1016\/j.cvsm.2015.06.004_bib127","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jcjo.2014.08.007","article-title":"Exciting directions in glaucoma. Canadian journal of ophthalmology","volume":"49","author":"Rasmussen","year":"2014","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.cvsm.2015.06.004_bib128","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2015.01.023","article-title":"Sustained drug release by contact lenses for glaucoma treatment-a review","volume":"202","author":"Carvalho","year":"2015","journal-title":"J\u00a0Control Release"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib129","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2012.06.017","article-title":"Extended drug delivery by contact lenses for glaucoma therapy","volume":"162","author":"Peng","year":"2012","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.cvsm.2015.06.004_bib130","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.exer.2014.06.013","article-title":"28-day intraocular pressure reduction with a single dose of brimonidine tartrate-loaded microspheres","volume":"125","author":"Fedorchak","year":"2014","journal-title":"Exp Eye Res"},{"issue":"4","key":"10.1016\/j.cvsm.2015.06.004_bib131","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/bjophthalmol-2013-304028","article-title":"Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine","volume":"98","author":"Kim","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.cvsm.2015.06.004_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.4.1.1","article-title":"Nanosponge-mediated drug delivery lowers intraocular pressure","volume":"4","author":"Lambert","year":"2015","journal-title":"Transl Vis Sci Technol"},{"issue":"11","key":"10.1016\/j.cvsm.2015.06.004_bib133","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1167\/iovs.14-14800","article-title":"Induction of trabecular meshwork cells from induced pluripotent stem cells","volume":"55","author":"Ding","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.cvsm.2015.06.004_bib134","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1167\/iovs.14-15266","article-title":"Neural stem cell-based intraocular administration of ciliary neurotrophic factor attenuates the loss of axotomized ganglion cells in adult mice","volume":"55","author":"Flachsbarth","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cvsm.2015.06.004_bib135","article-title":"Treatment of ocular disorders by gene therapy","author":"Solinis","year":"2014","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Veterinary Clinics of North America: Small Animal Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561615000893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561615000893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T08:38:39Z","timestamp":1748594319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195561615000893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":135,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0195561615000893"],"URL":"https:\/\/doi.org\/10.1016\/j.cvsm.2015.06.004","relation":{},"ISSN":["0195-5616"],"issn-type":[{"value":"0195-5616","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical Treatment of Primary Canine Glaucoma","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Small Animal Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cvsm.2015.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}